Archive for January 2024
Bristol Myers, J&J fund Lexington cancer biotech’s move into the clinic
A Lexington cancer biotech has attracted Series C funding from the likes of Bristol Myers Squibb, Johnson & Johnson’s venture capital arm and a newly launched biotech VC firm. Read More
Read MoreEmpty office building near TD Garden may be reborn as a hotel
Several office buildings downtown are to be turned into apartments. This Bulfinch Triangle property is slated for a different kind of conversion: office-to-hotel. Read More
Read MoreCommentary: A policy change needed to address the nursing shortage in Mass.
Most states allow nurses licensed in another state to move to their states and work here. Massachusetts doesn’t, and with the current healthcare workforce crisis, that needs to change, two policy experts write. Read More
Read MoreHealey’s local tax package gets cool reception in Legislature
The two top Democrats in the Legislature hesitated Monday to get behind proposals from Gov. Maura Healey regarding raising local taxes and draining one-time funds to pay for emergency shelter. Read More
Read MoreRockland Trust report rise in delinquent loans in Q4
Delinquencies for Independent Bank, the holding company for Rockland Trust, saw an increase from 0.22% to 0.44% in the fourth quarter of 2023. Read More
Read MoreMass. firm buys Merrimack, New Hampshire, plaza anchored by Shaw’s
Merrimack Village Center, a 82,300-square-foot plaza anchored by a Shaw’s supermarket, had been owned by another Massachusetts-based real estate firm. Read More
Read MoreSpirit, JetBlue appeal court decision blocking its $3.8 billion merger
A Massachusetts judge ruled that the merger would harm consumers by decreasing competition. The airlines disagreed, saying the combination would boost competitiveness and lower fares. Now, Spirit and JetBlue are appealing the decision. Read More
Read MoreHere’s how much Mass. biotechs hiked drug costs so far in 2024
The start of a new year is typically the prime period when drugmakers raise the list prices of their brand name medicines. Here’s a look at which Massachusetts companies have hiked drug costs so far in 2024, and by how much. Read More
Read MoreFormer Blue Cross executive Manny Lopes to become CEO of Fallon Health
Manny Lopes, current interim CEO of Fenway Health and former executive at Blue Cross, will soon run Fallon Health. Read More
Read MoreThe National Observer: Citigroup is slashing 20,000 jobs, but it’s hardly alone among bank giants
Banking heavyweights slashed thousands of jobs in 2023, and early indications are 2024 could bring more of the same. What’s fueling the trend? We cover that, a blocked airline merger and more in this week’s The National Observer. Read More
Read More